Palatin Technologies palatin.com


Public lists: Pharma Startups (4732)

Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.

Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and ...Show all

Company (IPO / Went public)

Phone: 609-495-2200

Fax:

4-B Cedar Brook Drive
Cedar Brook Corporate Center
Cranbury, 08512
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Palatin Technologies $113.9M Apr 12, 2006
Pharmaceutical Product Development $82.5M Apr 27, 2017
Biolog $0M Oct 16, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Palatin Technologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 44 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Uses of bremelanotide in therapy for female sexual dysfunction May 05, 2015 Jul 11, 2017 Patent
Melanocortin-1 receptor-specific linear peptides Dec 30, 2014 Feb 28, 2017 Patent
Melanocortin receptor-specific heptapeptides Jul 11, 2014 Oct 04, 2016 Patent
Uses of bremelanotide in therapy for female sexual dysfunction Jun 24, 2014 May 31, 2016 Patent
Peptidomimetics of biologically active metallopeptides Feb 10, 2004 Oct 05, 2010 Patent
See all 12 patents